Clinical Trials

Non-Small Cell Lung Cancer

Advanced

OSI2950g:  A randomized  Phase II study to evaluate the efficacy and safety of Bevacizumab (Avastin) in combination with Docetaxel (Taxotere), Pemetrexed Dosodium (Alimta) or Erlotinib Hydrochloride (Tarceva) compared with Docetaxel (Taxotere) pr Pemetrexed Disodium (Tarceva) alone for the treatment of patients with recurrent or refractory stage IIIB  stage IV non-small cell lung cancer. [UCLA]

For more information on VCHOS trials, please call Ruth Ann Begun at (805) 485-8709 ext 136 or email at rbegun@venturaoncology.com.   

For more information on  UCLA network trials, please call  Sharon Feinberg, RN at (805) 485-8709 ext 129 or email at sfeinberg@mednet.ucla.edu.